Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/38521
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWohlrab, Johannes-
dc.contributor.authorMarsch, Wolfgang Christian-
dc.date.accessioned2021-09-29T08:10:03Z-
dc.date.available2021-09-29T08:10:03Z-
dc.date.issued2020-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/38767-
dc.identifier.urihttp://dx.doi.org/10.25673/38521-
dc.description.sponsorshipPublikationsfonds MLU-
dc.language.isoger-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.subject.ddc610-
dc.titleTNF-Inhibitoren zur Therapie des Steven-Johnson-Syndrom/toxisch epidermale Nekrolyseger
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleJournal der Deutschen Dermatologischen Gesellschaft-
local.bibliographicCitation.volume18-
local.bibliographicCitation.issue9-
local.bibliographicCitation.pagestart1044-
local.bibliographicCitation.pageend1045-
local.bibliographicCitation.publishernameWiley-Blackwell-
local.bibliographicCitation.publisherplaceBerlin-
local.bibliographicCitation.doi10.1111/ddg.14228-
local.openaccesstrue-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
ddg.14228.pdf1.59 MBAdobe PDFThumbnail
View/Open